SKOR2

Chr 18

SKI family transcriptional corepressor 2

Also known as: CH18515, CORL2, FUSSEL18, VAFCAS

Enables SMAD binding activity and sequence-specific double-stranded DNA binding activity. Involved in negative regulation of transforming growth factor beta receptor signaling pathway. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…

Primary Disease Associations & Inheritance

UniProtValence-Farazi cerebellar ataxia syndrome

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
4
Pubs (1 yr)
P/LP submissions
P/LP missense
0.44
LOEUF
LOF
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.44LOEUF
pLI 0.754
Z-score 3.25
OE 0.17 (0.080.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.63Z-score
OE missense 0.72 (0.640.81)
193 obs / 268.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.17 (0.080.44)
00.351.4
Missense OE?0.72 (0.640.81)
00.61.4
Synonymous OE?1.13
01.21.6
LoF obs/exp: 3 / 17.8Missense obs/exp: 193 / 268.2Syn Z: -1.09

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SKOR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →